Over a million lives lost to a preventable disease – it's a staggering reality that demands our attention. Tuberculosis (TB), a centuries-old scourge, claimed 1.23 million lives last year, according to the World Health Organization (WHO). While this marks a 3% decline in deaths compared to previous years, and a 2% drop in overall cases since 2023, the fight against TB is far from over. But here's where it gets concerning: this progress, the first since the COVID-19 pandemic disrupted global health efforts, is hanging by a thread due to a critical shortage of funding.
The WHO's annual TB report, released on Wednesday, highlights a glimmer of hope: a record-breaking 8.3 million people accessed TB treatment after receiving a new diagnosis in 2024, and treatment success rates climbed from 68% to 71%. And this is the part most people miss: despite these advancements, the WHO chief, Tedros Adhanom Ghebreyesus, warns that these hard-won gains are at risk of being reversed due to a staggering funding gap.
Only $5.9 billion was available for TB prevention, diagnosis, and treatment last year, falling drastically short of the $22 billion annual target set for 2027. This raises a crucial question: Can we afford to let financial constraints undermine our progress against a disease that's both preventable and curable?
Tedros emphasizes, “Declines in the global burden of TB and progress in testing, treatment, social protection, and research are all welcome news after years of setbacks, but progress is not victory.” He further laments, “The fact that TB continues to claim over a million lives each year despite being preventable and curable is simply unconscionable.”
While TB deaths in 2024 were 29% lower than in 2015, the WHO's ambitious goals of reducing deaths by 75% by 2025 and 90% by 2030 seem increasingly distant. Here's a sobering thought: Tereza Kasaeva, director of WHO’s division for tuberculosis, HIV, and related infections, warns that long-term cuts to international donor funding could lead to a devastating reversal, resulting in up to 2 million additional deaths and 10 million new TB cases between 2025 and 2035.
The situation is further exacerbated by the United States' withdrawal from the WHO in January, forcing a 21% cut to the agency's proposed spending. The Trump administration's decision to slash foreign aid, particularly from the US Agency for International Development, has sent shockwaves through global health efforts, raising serious concerns about the future of TB treatment worldwide.
Last year, international aid played a crucial role in preventing 3.65 million TB deaths, according to the WHO. The question remains: Will the world prioritize funding to sustain this progress, or will we allow TB to reclaim its devastating grip on millions of lives?
This isn't just a public health issue; it's a moral imperative. We have the tools to defeat TB, but we need the collective will and resources to make it happen. What do you think? Is enough being done to combat this preventable disease? Share your thoughts in the comments below.
